Cabo Verde vs Sierra Leone: Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology
Cabo Verde
0.7%
in 2024
Sierra Leone
0.7%
in 2024
Cabo Verde rank
51st
Sierra Leone rank
51st
Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology over time
- Cabo Verde
- Sierra Leone
How they compare
Cabo Verde currently reports 0.7% against 0.7% in Sierra Leone, a difference of 0.0%.
Across all 10 years both countries report, Sierra Leone has been ahead every year.
Cabo Verde ranks 51st and Sierra Leone ranks 51st of 247 countries.
Sierra Leone has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Cabo Verde | Sierra Leone | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 0.8% | 1.3% | 0.4% | Sierra Leone |
| 2020s | 0.6% | 0.8% | 0.2% | Sierra Leone |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher prevalence of hepatitis b surface antigen (hbsag), 2026 methodology, Cabo Verde or Sierra Leone?
- Cabo Verde, at 0.7% against 0.7% in Sierra Leone as of 2024.
- What is the difference in prevalence of hepatitis b surface antigen (hbsag), 2026 methodology between Cabo Verde and Sierra Leone?
- 0.0%, with Cabo Verde ahead.
- How many years of comparable data are there for Cabo Verde and Sierra Leone?
- 10 years are reported by both, from 2015 to 2024.
- How do Cabo Verde and Sierra Leone rank globally for prevalence of hepatitis b surface antigen (hbsag), 2026 methodology?
- Cabo Verde ranks 51st and Sierra Leone ranks 51st of 247 countries.
- Where does this data come from?
- United Nations Statistics Division, SDG Global Database, published as Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.